Skip to main content
NeuronFeed
Home Investors Mubadala Capital

Mubadala Capital

Active VC
Portfolio Active
4
Latest Paradigm Health
Deal flow
$23.2B
6 rounds
Unicorns
2
≥ $1B valuation
Founded
—
Latest
Sep 2026
Crusoe

About Mubadala Capital

Venture capital firm tracking 4 AI investments, with focus on Drug Discovery and US startups. Total tracked deal flow: $23.2B.

Investment activity

2025–2026
$78M
$22.9B
1
'25
3
'26

Sector focus

💊 Drug Discovery 3
🏢 AI Infrastructure 2
🧠 Foundation Models 2
🛠️ AI Developer Tools 2
🏥 AI Healthcare 2
🚗 Autonomous Vehicles 1
🦾 AI Robotics 1

Geographic focus

US 3

Portfolio

4

Paradigm Health

AI research platform making clinical trials part of routine patient care

Crusoe

Sustainable AI cloud infrastructure

Waymo

The world's most experienced autonomous driver

Ollin Biosciences

Biotech advancing best-in-class bispecific antibody therapies for eye disease, using AI and

Co-investors

8

ARCH Venture Partners

3 shared

GV (Google Ventures)

3 shared

Atreides Management

2 shared

F-Prime

2 shared

DFJ Growth

2 shared

Valor Equity Partners

2 shared

Lux Capital

2 shared

General Catalyst

2 shared

Recent rounds

6
Sep 17, 2026 Series F $3.9B Crusoe
Sep 3, 2026 Other $3B Crusoe
Feb 2, 2026 Series G $16B Waymo
Dec 4, 2025 Series B $78M Paradigm Health
Series B $78M Paradigm Health
Series A $100M Ollin Biosciences